SEBI Reg. Investment Advisor

Download App

Help Center Subscribe

Recent:

Top Pharma Companies in India by Market Cap

BSE Sensex 78039.03
536.91 (0.69%)

Filter

Top Pharma Companies in India as on Jul-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

	Company Name	DeciZen	Market cap (Rs. Cr.)	CMP (Change %)	Latest P/E	Latest P/BV	5Y Sales Gr.(%)	5Y Profit Gr.(%)
121	Nectar Lifesciences Ltd.	Q V PT	230 Small Cap	11.94 (0.76%)	N/A	0.4	-6.71	-232.05	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
122	Sanofi India Ltd.	Q V PT	8,006 Small Cap	3,460.10 (-0.46%)	25.84	10.26	-8.74	-7.50	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
123	Panacea Biotec Ltd.	Q V+ PT	3,353 Small Cap	543.75 (-0.66%)	N/A	11.75	-8.75	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
124	Aster DM Healthcare Ltd.	Q V+ PT	40,963 Mid Cap	790.20 (-0.05%)	105.54	8.95	-13.71	0.61	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
125	Suven Life Sciences Ltd.	Q V+ PT	7,884 Small Cap	318.80 (6.75%)	N/A	5.24	-14.30	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
126	Jubilant Pharmova Ltd.	Q V+ PT	15,492 Small Cap	975.95 (0.34%)	778.52	6.7	-24.99	-38.93	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
Prev 1 2 3 4 5 Next

Screens:

AlphaCases Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks

Pharma - Today's Top Gainers

Company Name	CMP	Price Change(%)
Fabtech Technologies	172.95	6.92%
Suven Life Sciences	318.80	6.75%
Themis Medicare	123.25	3.44%
Caplin Point Labs.	2,617.60	2.76%
Narayana Hrudayalay.	2,037.90	2.65%

Pharma - Today's Top Losers

Company Name	CMP	Price Change(%)
Orchid Pharma	949.10	-2.91%
Bliss GVS Pharma	512	-2.75%
IOL Chem & Pharma	147	-2.13%
Kwality Pharma	2,677	-1.73%
Innova Captab	969.30	-1.03%

News about Top Pharma Companies in India

Jul, 2026

Jubilant Pharmova informs about compliances-certificate

In terms of Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, Jubilant Pharmova has enclosed a confirmation Certificate for the quarter ended on June 30, 2026 received from Alankit Assignments, Registrar and Share Transfer Agent of the Company.

The above information is a part of company’s filings submitted to BSE.

Jun, 2026

USFDA concludes inspection at Jubilant Pharmova’s arm’s facility in U.S.A

JHS will respond to the inspection observations within 15 business days

Jun, 2026

Jubilant Pharmova informs about completion of USFDA inspection

Jubilant Pharmova has informed that the USFDA has completed an inspection of the Jubilant HollisterStier LLC (‘JHS’) CMO business at Spokane WA, U.S.A facility. The company has enclosed the details regarding the dates of the inspection and outcome of the inspection in accordance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Date and Time of receipt - June 17, 2026, 15:30 PM (PST), June 18, 2026, 04:00 am (IST).

The above information is a part of company’s filings submitted to BSE.

Jun, 2026

Aster DM Healthcare informs about acquisition

Pursuant to Regulation 30 of the SEBI Listing Regulations, Aster DM Healthcare has informed that the Company today, i.e. June 18, 2026, has acquired 4,50,89,995 equity shares of Rs 10 each through rights issue in the Sarjapur Entity. The details as required under Regulation 30 of the SEBI Listing Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, are given in ‘Annexure I’. The above-mentioned information will also be available on the website of the Company at https://www.asterdmhealthcare.in.

The above information is a part of company’s filings submitted to BSE.

Jun, 2026

Panacea Biotec informs about disclosures

Panacea Biotec has informed that it enclosed disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr Rajesh Jain.

The above information is a part of company’s filings submitted to BSE.

Jun, 2026

Panacea Biotec informs about newspaper publication

Panacea Biotec has informed that it enclosed newspaper copies regarding notice intimating the investors about the opening of a Special Window for Transfer and Dematerialization of physical shares, in accordance with SEBI Circular No. HO/38/13/11(2)2026-MIRSD-POD/I/3750/2026 dated January 30, 2026, published on June 16, 2026, in the newspapers: Financial Express; and Desh Sewak (Punjabi).

The above information is a part of company’s filings submitted to BSE.

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Rank	Company	Market Capitalization 2026 (INR crores)
1	Health X Platform Ltd.	989 Crore
2	Fischer Medical Ventures Ltd.	2,558 Crore
3	3B Blackbio Dx Ltd.	1,037 Crore
4	Max Healthcare Institute Ltd.	1,09,728 Crore
5	Indegene Ltd.	12,397 Crore
6	Acutaas Chemicals Ltd.	30,212 Crore
7	Rubicon Research Ltd.	22,733 Crore
8	Yatharth Hospital & Trauma Care Services Ltd.	8,313 Crore
9	Dr. Agarwals Health Care Ltd.	15,099 Crore
10	Innova Captab Ltd.	5,605 Crore

Do you know? Asking 3 Right Questions minimizes the RISK of Stock Investing To Know

Right Stock | Right Price | Right Allocation

Find best stocks to buy now Find best pharma stocks to buy now

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Abbott India Ltd. (M)	Very Good	25,765	54,657	35.22	11.45	24.04	35.71
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,744	1,57,804	72.94	18.81	38.40	29.04
Ajanta Pharma Ltd. (M)	Very Good	3,390	41,776	39.56	9.23	26.73	25.35
Lupin Ltd. (M)	Somewhat Good	2,439	1,09,676	20.57	4.89	11.90	20.83
Zydus Lifesciences Ltd. (M)	Very Good	1,116	1,09,691	21.76	4.22	13.36	20.74

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Laurus Labs Ltd. (M)	Very Good	1,535	82,399	101
JB Chemicals & Pharmaceuticals Ltd. (S)	Very Good	2,357	37,225	41.28
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,744	1,57,804	39.25
Aurobindo Pharma Ltd. (M)	Very Good	1,597	89,762	34.75
Ajanta Pharma Ltd. (M)	Very Good	3,390	41,776	31.18
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
JB Chemicals & Pharmaceuticals Ltd. (S)	Very Good	2,357	37,225	55.22	9.22	33.44	15.51
Mankind Pharma Ltd. (M)	Very Good	2,502	1,02,729	50.42	6.27	31.67	14.65
Ajanta Pharma Ltd. (M)	Very Good	3,390	41,776	39.56	9.23	26.73	13.54
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,369	1,12,368	26.78	2.98	14.95	12.09
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,744	1,57,804	72.94	18.81	38.40	11.80

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Zydus Lifesciences Ltd. (M)	Very Good	1,116	1,09,691	21.76	4.22	13.36	30.57
Sun Pharmaceutical Industries Ltd. (L)	Very Good	1,903	4,49,048	39.12	5.37	22.41	23.50
Abbott India Ltd. (M)	Very Good	25,765	54,657	35.22	11.45	24.04	18.78
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,369	1,12,368	26.78	2.98	14.95	15.75
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,217	61,943	45.48	5.89	12.07	14.41

You have 7 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now

Create stable, long-term investment portfolio with strong, consistent stocks.

Start Research-backed Investing ...Now. Subscribe to Sapphire

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Fiduciary-first advisory model.
As SEBI-registered IAs, we are legally and ethically bound to act in the best interests of our clients. We do not sell or distribute any financial products. This ensures our guidance is 100% unbiased and conflict-free.
Deep fundamental research + robust valuation discipline.
Built on more than 15 years of equity research, our framework combines quality assessment, intrinsic value estimation, and a sensible margin-of-safety approach.
Process—not predictions.
We don’t rely on guesswork or market timing. Instead, we focus on asset allocation, risk management, and long-term compounding.
Technology + Human Intelligence.
We believe a combination of both is essential for investing success. We constantly innovate and upgrade in-house tools, financial X-rays, and portfolio analytics so that our team of analysts and advisors are equipped with the best.
Partner with Clients.
We follow a DIWM (Do-It-With-Me) approach where we partner clients in setting goals, financial planning, educating on our investing process and share decision-enabling resources transparently with our clients who retain control on execution.

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

Investing in stocks, mutual funds, debt, and gold
Quality-at-Reasonable-Price way of investing in stocks
Constructing Direct Stock Portfolios with Core, Booster, and Amplifier stocks
A Mutual Fund Portfolio that delivers consistent out-performance and meaningful diversification (low overlap)
Periodic review and rebalancing
Clear Buy-Sell-Hold, and Position-sizing frameworks

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Top Pharma Companies in India by Market Cap

News about Top Pharma Companies in India

Jubilant Pharmova informs about compliances-certificate

USFDA concludes inspection at Jubilant Pharmova’s arm’s facility in U.S.A

Jubilant Pharmova informs about completion of USFDA inspection

Aster DM Healthcare informs about acquisition

Panacea Biotec informs about disclosures

Panacea Biotec informs about newspaper publication

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

How to select the top Nifty Pharma stocks based on RoE?

What are the best-performing stocks in the Nifty Pharma index?

Which Nifty Pharma stocks have the highest revenue growth in the past five years?

Which Nifty Pharma stocks had the highest profit growth in the past five years ?

Create stable, long-term investment portfolio with strong, consistent stocks.

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.